PTGX
Protagonist Therapeutics Inc

3,360
Mkt Cap
$5.04B
Volume
379.00
52W High
$96.54
52W Low
$33.70
PE Ratio
127.36
PTGX Fundamentals
Price
$80.67
Prev Close
$83.30
Open
$83.62
50D MA
$85.98
Beta
0.42
Avg. Volume
870,278.30
EPS (Annual)
$4.23
P/B
7.80
Rev/Employee
$3.45M
Loading...
Loading...
News
all
press releases
Equities Analysts Set Expectations for PTGX FY2030 Earnings
Protagonist Therapeutics, Inc. (NASDAQ:PTGX - Free Report) - Research analysts at HC Wainwright issued their FY2030 earnings estimates for Protagonist Therapeutics in a report released on Friday...
MarketBeat·4d ago
News Placeholder
More News
News Placeholder
Protagonist Therapeutics Chief Medical Officer Sells PTGX 9,514 Shares for $784K to Cover Taxes
Key PointsArturo Molina sold 9,514 directly on Jan. 20, 2026, generating a transaction value of approximately $784,700 at a reported price of $82.48 per share...
Nasdaq News: Markets·5d ago
News Placeholder
Breaking Down Protagonist Therapeutics: 8 Analysts Share Their Views
read more...
Benzinga·7d ago
News Placeholder
Protagonist Therapeutics, Inc. $PTGX Shares Sold by Great Lakes Advisors LLC
Great Lakes Advisors LLC decreased its holdings in Protagonist Therapeutics, Inc. (NASDAQ:PTGX - Free Report) by 36.0% in the 3rd quarter, according to the company in its most recent 13F filing with...
MarketBeat·7d ago
News Placeholder
Universal Beteiligungs und Servicegesellschaft mbH Raises Stock Position in Protagonist Therapeutics, Inc. $PTGX
Universal Beteiligungs und Servicegesellschaft mbH raised its stake in shares of Protagonist Therapeutics, Inc. (NASDAQ:PTGX - Free Report) by 123.1% in the third quarter, according to the company in...
MarketBeat·10d ago
News Placeholder
Protagonist Therapeutics, Inc. (NASDAQ:PTGX) Given Consensus Recommendation of "Moderate Buy" by Analysts
Shares of Protagonist Therapeutics, Inc. (NASDAQ:PTGX - Get Free Report) have received a consensus rating of "Moderate Buy" from the thirteen ratings firms that are presently covering the stock...
MarketBeat·12d ago
News Placeholder
Insider Selling: Protagonist Therapeutics (NASDAQ:PTGX) CFO Sells 8,588 Shares of Stock
Protagonist Therapeutics, Inc. (NASDAQ:PTGX - Get Free Report) CFO Asif Ali sold 8,588 shares of Protagonist Therapeutics stock in a transaction that occurred on Tuesday, January 20th. The shares...
MarketBeat·15d ago
News Placeholder
Asif Ali Sells 8,588 Shares of Protagonist Therapeutics (NASDAQ:PTGX) Stock
Protagonist Therapeutics, Inc. (NASDAQ:PTGX - Get Free Report) CFO Asif Ali sold 8,588 shares of the firm's stock in a transaction dated Tuesday, January 20th. The stock was sold at an average price...
MarketBeat·16d ago
News Placeholder
Protagonist Therapeutics (NASDAQ:PTGX) Insider Arturo Md Molina Sells 9,514 Shares
Protagonist Therapeutics, Inc. (NASDAQ:PTGX - Get Free Report) insider Arturo Md Molina sold 9,514 shares of the company's stock in a transaction dated Tuesday, January 20th. The shares were sold at...
MarketBeat·16d ago
News Placeholder
Protagonist Therapeutics (NASDAQ:PTGX) CEO Sells $2,840,446.24 in Stock
Protagonist Therapeutics, Inc. (NASDAQ:PTGX - Get Free Report) CEO Dinesh Ph Patel sold 34,438 shares of Protagonist Therapeutics stock in a transaction that occurred on Tuesday, January 20th. The...
MarketBeat·16d ago
<
1
2
...
>

Latest PTGX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.